Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt
SD is prevalent in patients who undergo TIPS. MHE is an independent risk factor for the development of SD post-TIPS. Eszopiclone may be a safe and effective treatment option for patients with SD after TIPS. The study was registered with ClinicalTrials.gov under the identifier NCT03685994, with a registration date of September 23, 2018.
Authors
- Liu Bang-xi
- Xiaoze Wang (ORCID: https://orcid.org/0000-0002-7169-9467)
- Yuling Yan (ORCID: https://orcid.org/0000-0002-2765-8350)
- Xuefeng Luo (ORCID: https://orcid.org/0000-0002-3992-5866)
- Ming Zhao (ORCID: https://orcid.org/0000-0003-3147-1764)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1186/s12876-024-03470-x
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- West China Hospital, Sichuan University